The TYMS-TSER polymorphism is associated with toxicity of low-dose capecitabine in patients with advanced gastrointestinal cancer. Anti-Cancer Drugs
No evidence of NRAS mutation in squamous cell anal carcinoma (SCAC). Scientific Reports
Laura Capelli1, Andrea Casadei Gardini2, Emanuela Scarpi3, Giovanni Luca Frassineti2, Luca Saragoni4, Maurizio Puccetti5, Mario Scartozzi6, Massimo Giannini7, Stefano Tamberi8, Jody Corbelli8 & Paola Ulivi1 1Biosciences Laboratory, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, Italy 2Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura […]
Small cell lung cancer transformation and the T790M mutation: A case report of two acquired mechanisms of TKI resistance detected in a tumor rebiopsy and plasma sample of EGFR-mutant lung adenocarcinoma. Oncology Letters
Liquoral liquid biopsy in neoplastic meningitis enables molecular diagnosis and mutation tracking: a proof of concept. Neuro-Oncology
Role of surgical resection in recurrent glioblastoma: prognostic factors and outcome evaluation in an observational study. Journal of Neuro-Oncology
Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial. Breast Cancer Research
Harriet Johansson1, Kathryn P. Gray2, Olivia Pagani3,4,5, Meredith M. Regan6, Giuseppe Viale7, Valentina Aristarco1, Debora Macis1, Antonella Puccio1, Susanne Roux8, Rudolf Maibach8, Marco Colleoni1, Manuela Rabaglio9, Karen N. Price9,10, Alan S. Coates11, Richard D. Gelber12, Aron Goldhirsch13, Roswitha Kammler14, Bernardo Bonanni1†, Barbara A. Walley15,16† and the TEXT principal investigators 1Division of Cancer Prevention and Genetics, […]
RAS testing practices and RAS mutation prevalence among patients with metastatic colorectal cancer: results from a Europe-wide survey of pathology centres. BMC Cancer
Annemarie Boleij1, Véronique Tack2, Aliki Taylor3, George Kafatos3, Sophie Jenkins-Anderson4, Lien Tembuyser2, Els Dequeker2 and J. Han van Krieken1 1Department of Pathology, Radboud University Medical Centre 2Department of Public Health and Primary Care, University of Leuven 3Centre for Observational Research, Amgen Ltd 4Adelphi Research (Global) Abstract: Background Treatment options for patients with metastatic colorectal cancer […]